Advaxis, Inc. (ADXS) Down 10% Today: What Do Hedge Funds Think about this …
Advaxis, Inc. (NASDAQ:ADXS) is a biotechnology company which focuses on developing drug technology for treating Cancer. Alongside many other biotech stocks, Advaxis, Inc. (NASDAQ:ADXS)’s shares surged by 108% so far in 2015. However, in the last 30 days, the stock is down by 25%. Today, Advaxis is down by around 10%, after jumping by 17% on Tuesday. There have been […]